VRCA Q4 2021 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$56M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$200,000

Operating Income

-$8M

Net Income

-$10M

EPS (Diluted)

$-3.47

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$80M

Total Liabilities

$48M

Stockholders' Equity

$33M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$200,000	$0	—
Operating Income	-$8M	-$12M	+29.6%
Net Income	-$10M	-$13M	+26.5%